Feasibility Study of Particle-Assisted Laser Ablation of Brain Tumors in Orthotopic Canine Model

¹Nanospectra Biosciences, Inc.; ²University of Texas M. D. Anderson Cancer Center; ³Center for Comparative Medicine, Baylor College of Medicine; ⁴Visualase, Inc., Houston, Texas

^* To whom correspondence should be addressed. E-mail: jschwartz{at}nanospectra.com.

	Abstract

We report on a pilot study showing a proof of concept for the passive delivery of nanoshells to an orthotopic tumor where they induce a local, confined therapeutic response distinct from that of normal brain resulting in the photothermal ablation of canine transmissible venereal tumor (cTVT) in a canine brain model. cTVT fragments grown in severe combined immunodeficient mice were successfully inoculated in the parietal lobe of immunosuppressed, mixed-breed hound dogs. A single dose of near-IR (NIR)–absorbing, 150-nm nanoshells was infused i.v. and allowed time to passively accumulate in the intracranial tumors, which served as a proxy for an orthotopic brain metastasis. The nanoshells accumulated within the intracranial cTVT, suggesting that its neovasculature represented an interruption of the normal blood-brain barrier. Tumors were thermally ablated by percutaneous, optical fiber–delivered, NIR radiation using a 3.5-W average, 3-minute laser dose at 808 nm that selectively elevated the temperature of tumor tissue to 65.8 ± 4.1°C. Identical laser doses applied to normal white and gray matter on the contralateral side of the brain yielded sublethal temperatures of 48.6 ± 1.1°C. The laser dose was designed to minimize thermal damage to normal brain tissue in the absence of nanoshells and compensate for variability in the accumulation of nanoshells in tumor. Postmortem histopathology of treated brain sections showed the effectiveness and selectivity of the nanoshell-assisted thermal ablation. [Cancer Res 2009;69(4):1659–67]

Key Words: brain, laser, nanoshells